3 February 2020 - Advances in health care due to the development and introduction of new drugs and medical devices have brought considerable benefits to people and patients in terms of upgraded quality of life and extended years of survival. 

However, some are concerned that the very advancement of health care would increase further the inflation of national healthcare costs. 

In response to these concerns, Japan's Central Social Insurance Medical Council (“Chuikyo”) began in 2012 to examine how cost-effectiveness evaluation might be applied to the national health insurance system, and has been working toward establishing a system for its usage.

Read International Journal of Technology Assessment in Health Care article